Compounding Knowledge: Decoding Immediate-Use and Category 1 Compounding - February 2026

Includes a Live Web Event on 02/11/2026 at 12:00 PM (EST)

Recorded On: 02/11/2026

As more small organizations begin sterile compounding, understanding Immediate Use and Category 1 Compounding is critical. This session breaks down the definitions, key differences, and regulatory requirements for these compounding types when conducted in Segregated Compounding Areas (SCAs). We'll discuss when these practices are appropriate, how to stay compliant, and practical considerations for implementation.

  1. Distinguish between Immediate-Use and Category 1 Compounding, including definitions, requirements, and appropriate use cases.
  2. Explain regulatory expectations for conducting these compounding activities in SCAs.
  3. Evaluate practical considerations and compliance strategies for implementing Immediate-Use and Category 1 practices in small organizations.

Lilit Karayan, PharmD, MBA, BCSCP

Home Infusion Manager

Baptist Health South Florida

Lilit Karayan Pharm.D., MBA, BCSCP serves as the Home Infusion Manager at Baptist Health South Florida. She received her Doctor of Pharmacy in 2007 and MBA in 2015 both from the University of Connecticut. In 2019 she achieved Board Certification as a Sterile Compounding Pharmacist. 

She recently opened the home infusion service line and continues to expand the operation. Prior to this Dr. Karayan held the role of Manager for Compounding and Compliance.  She worked with the 12 hospitals within the health system in standardizing cleanroom design, policy development, outsourcing oversight and staff training, competency and education.  

NHIA Requires planners, faculty, and others who affect the content of this activity to disclose all financial relationships they have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to policy. 

Lilit Karayan has no relevant financial relationships with ineligible companies to disclose.

Key:

Complete
Failed
Available
Locked
Compounding Knowledge: Decoding Immediate-Use and Category 1 Compounding - Live
02/11/2026 at 12:00 PM (EST)  |  30 minutes
02/11/2026 at 12:00 PM (EST)  |  30 minutes
You must register to access.
Post Education Survey - Live
8 Questions
8 Questions Compounding Knowledge: Decoding Immediate-Use and Category 1 Compounding NHIA Live Webinar, 0.50 CE
You must register to access.
Required to Claim Live CE
Up to 0.50 medical credits available  |  Certificate available
Up to 0.50 medical credits available  |  Certificate available **PHARMACISTS & PHARMACY TECHNICIANS MUST SELECT THE BLUE "CLAIM CREDIT" BUTTON & ENTER YOUR DOB IN ORDER TO RECEIVE CE CREDIT** ________________________________________________________________________________________________________________________________________________________________________ NHIA adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Medical Education. Any individuals in a position to control the content of a CME/CE activity, including faculty, panelists, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity. Please note that the certificates printed from this platform are invalid as proof of continuing education (CE). For official documentation of CE credits, please print a paper statement of credit from your NABP e-profile.
You must register to access.